ArticleBlood2012

Dasatinib may overcome the negative prognostic impact of KIR2DS1 in newly diagnosed patients with chronic myeloid leukemia.

Sara Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.